.Beta.-Hydroxyisovaleric Acid

.Beta.-Hydroxyisovaleric Acid

SCHEMBL1409113

CC(C)(O)CC(=O)[O-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of .Beta.-Hydroxyisovaleric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117510325-A Refining method of beta-hydroxy-beta-methylbutyric acid 湖北远大生命科学与技术有限责任公司 2024-02-06 CN claimed
CN-116814797-A Primer combination for PCR identification of ground beetle medicinal materials, standard decoction and traditional Chinese medicine formula particles, application thereof and identification method 广东一方制药有限公司 2023-09-29 CN claimed
CN-116004839-A Primer for multiple STR typing of Zaocys medicinal material, standard decoction and traditional Chinese medicine formula granule, application thereof and identification method 广东一方制药有限公司 2023-04-25 CN claimed
CN-116004838-A Multiple STR typing primer for Bungarus Parvus medicinal material, standard decoction and traditional Chinese medicine formula granule, application thereof and identification method 广东一方制药有限公司 2023-04-25 CN claimed
CN-115261452-A Bombyx Batryticatus and specific PCR identification method for decoction pieces, water extract products and formula granules of Bombyx Batryticatus and application of method 广东一方制药有限公司 2022-11-01 CN claimed
CN-115067518-A Composition for improving immunity of tumor patients 广东特芯生物科技有限公司 2022-09-20 CN claimed
CN-115040550-A Composition for increasing immunoglobulin G 广东特芯生物科技有限公司 2022-09-13 CN claimed
CN-115040549-A Composition for tumor 广东特芯生物科技有限公司 2022-09-13 CN claimed
CN-114990230-A Multiple specificity PCR identification method for stiff silkworm and fried stiff silkworm extract and application of multiple specificity PCR identification method in Chinese patent medicine identification 广东一方制药有限公司 2022-09-02 CN claimed
CN-114657256-A Primer combination for PCR identification of Bungarus parvus medicinal materials, standard decoction and traditional Chinese medicine formula granules, application and identification method thereof 广东一方制药有限公司 2022-06-24 CN claimed
US-20120189714-A1 COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE ABBOTT LABORATORIES (US) 2012-07-26 US claimed
US-20120189716-A1 METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR TREATING DISEASE-ASSOCIATED WASTING ABBOTT LABORATORIES (US) 2012-07-26 US claimed
US-20120177752-A1 NUTRITIONAL COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE ABBOTT LABORATORIES (US) 2012-07-12 US claimed
CN-100542525-C The method for preparing 3-hydroxy-3-methyl sodium butyrate solid preparation LONZA AG (CH) 2009-09-23 CN claimed
US-7026507-B2 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate LONZA AG (CH) 2006-04-11 US claimed
EP-1399138-B1 METHOD FOR THE PRODUCTION OF SOLID FORMULATIONS OF SODIUM 3-HYDROXY-3-METHYLBUTYRATE LONZA AG (CH) 2006-02-08 EP claimed
CN-1523983-A Method for preparing solid preparation of sodium 3-hydroxy-3-methylbutyrate ��¡���ӹɷ����޹�˾ 2004-08-25 CN claimed
US-20040143136-A1 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate LONZA AG (CH) 2004-07-22 US claimed
EP-1399138-A1 METHOD FOR THE PRODUCTION OF SOLID FORMULATIONS OF SODIUM 3-HYDROXY-3-METHYLBUTYRATE LONZA AG (CH) 2004-03-24 EP claimed
WO-2002094255-A1 METHOD FOR THE PRODUCTION OF SOLID FORMULATIONS OF SODIUM 3-HYDROXY-3-METHYLBUTYRATE LONZA AG (CH) 2002-11-28 WO claimed